This letter highlights the need for detailed echocardiographic and clinical baseline data when evaluating the stroke risk associated with device-detected atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Babayiğit et al. (2022) conducted a letter in Hypertension and a pacemaker. 14-day continuous electrocardiographic monitor was evaluated on Atrial fibrillation (AF) detection over 6 min.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: